Entity
  • Innate Pharma

    Created in 1999


  • Up & running (A)
    Existing signals show a regular activity
  • Social networks

    4,094 27,354
  • Activities

  • Technologies

  • Entity types

  • Location

    117 Av. de Luminy, 13009 Marseille, France

    Marseille

    France

  • Employees

    Scale: 201-500

    Estimated: 196

  • SIREN

    424365336
  • Engaged catalyst

    26
    0 0
  • Added in Motherbase

    5 years, 2 months ago
Description
  • Value proposition

    Innate Pharma S.A. is a global, clinical-stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer.

    Innate Pharma’s broad pipeline of antibodies includes several potentially first-in-class clinical and preclinical candidates in cancers with high unmet medical need.

    Innate has been a pioneer in the understanding of natural killer cell (NK cell) biology and has expanded its expertise in the tumor microenvironment and tumor-antigens, as well as antibody engineering. This innovative approach has resulted in a diversified proprietary portfolio and major alliances with leaders in the biopharmaceutical industry including Bristol-Myers Squibb Novo Nordisk A/S, Sanofi, and a multi-products collaboration with AstraZeneca.

    Based in Marseille, France, Innate Pharma is listed on Euronext Paris and Nasdaq in the US.

    biotechnologies, antibodies, immunotherapy, and oncology

  • Original language

    Innate Pharma S.A. is a global, clinical-stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer.

    Innate Pharma’s broad pipeline of antibodies includes several potentially first-in-class clinical and preclinical candidates in cancers with high unmet medical need.

    Innate has been a pioneer in the understanding of natural killer cell (NK cell) biology and has expanded its expertise in the tumor microenvironment and tumor-antigens, as well as antibody engineering. This innovative approach has resulted in a diversified proprietary portfolio and major alliances with leaders in the biopharmaceutical industry including Bristol-Myers Squibb Novo Nordisk A/S, Sanofi, and a multi-products collaboration with AstraZeneca.

    Based in Marseille, France, Innate Pharma is listed on Euronext Paris and Nasdaq in the US.

Catalyst interactions
Catalyst TypeTweets Articles
La Tribune
La Tribune
Media, Newspapers
La Tribune
Media, Newspapers
Other

22 May 2023


BFM Business
BFM Business
Media, Broadcast Media Production and Distribution
BFM Business
Media, Broadcast Media Production and Distribution
Other

15 Dec 2021

25 Nov 2023



Le Journal des Entreprises
Le Journal des Entreprises
Media, Newspaper Publishing
Le Journal des Entreprises
Media, Newspaper Publishing
Not capitalistic
Partnership
Not event

15 Nov 2024


Bpifrance
Bpifrance
Bank, Banking
Bpifrance
Bank, Banking
Not capitalistic
Partnership
Event

11 Aug 2020


La French Tech
La French Tech
Media, Government Administration
La French Tech
Media, Government Administration
Not capitalistic
Partnership
Event

7 Jun 2016


Grand Luminy Technopole
Grand Luminy Technopole
Business Consulting and Services
Grand Luminy Technopole
Business Consulting and Services
Not capitalistic
Not partnership
Event

3 Dec 2020

12 Nov 2024



Social network dynamics
Similar entities
BETA
Loading...
Loading...